baber/WOPTO huggingface dataset:
Patent JP-2724001-B2 (JP)
IPC: C07C29/145
Filed: 1989-10-26
Granted: 1998-03-09
Abstract: Isopropanol is prepared through catalytic hydrogenation of acetone by feeding hydrogen gas and acetone liquid into a reactor having a fixed catalyst bed from its top to form a cocurrent gas/liquid downflow while maintaining the catalyst bed in a trickle bed state. This process can produce isopropanol at a high reaction rate in high yields using a simple reactor.
Patent JP-2936201-B2 (JP)
IPC: C12N5/10
Filed: 1989-11-09
Granted: 1999-08-23
Abstract: The present invention relates to a novel DNA sequence coding for factor IX or an analogous protein, corresponding to a prosequence and to factor IX or to the mature analogous protein. According to the invention, the position (-3) in the prosequence is occupied by a codon coding for valine, arginine, lysine, threonine or serine and/or the first codon of the sequence coding for the mature protein codes for an alanine. Application to the expression of active factor IX in mammalian cells.
Patent JP-3201501-B2 (JP)
IPC: H01L21/56
Filed: 1993-12-27
Granted: 2001-08-20
Abstract: PURPOSE:To provide a method, by which defective junctions such as void between electronic parts such as LSI chips and a heat spreader for accelerating heat dissipation is prevented, the heat spreader having the excellent heat dissipation property is formed and a package part having the heat spreader, whose manufacturing process is simple, is formed. CONSTITUTION:An electrode 2 of an LSI chip is directed upward, and fixed to a polyimide tape 8. Then, a resin layer 9 is formed on the LSI chip l and the polyimide tape 8 other than a part of the electrode 2. An opening part 10a for exposing the electrode 2 and an opening part for exposing the rear surface of the LSI chip 1 are provided respectively. A metal plated film, which becomes a lead 13 to be connected to the electrode 2, is provided at the opening part 10a and the resin layer 9. A metal plated film, which becomes a heat spreader 12, is formed at the opening part 10b.
Patent JP-3444829-B2 (JP)
IPC: A61C13/225
Filed: 1999-11-22
Granted: 2003-09-08
Abstract: A ceramic denture insertable in cavities in two adjoining crown or bridge units has a joining element (26) which can be sintered at below ca. 800 degrees C into the cavities by a glass powder paste or dispersion. An Independent claim relates to forming a joint between cavities in two adjoining crown or bridge units by providing the volume between the joining unit and the cavity with a glass powder paste or dispersion, adjusting the geometry and melting, cooling and hardening to form the joint.
Patent JP-3172955-B2 (JP)
IPC: B41F17/00
Filed: 1992-12-21
Granted: 2001-06-04
Abstract: A method for printing identity cards (10) with a blind hole (12) provides for the hole to be at least partially filled at the moment of printing with an element (14) so that the bottom of the hole is pressed against the printing surface. The elements are either attached firmly to the counter-pressure surface of the device or are mounted movably in said surface. In the second case, the elements can disappear in the counter-pressure surface if required. <IMAGE>
Patent JP-4160634-B2 (JP)
IPC: C07C59/285
Filed: 1997-05-26
Granted: 2008-10-01
Abstract: PCT No. PCT/EP97/02693 Sec. 371 Date Nov. 30, 1998 Sec. 102(e) Date Nov. 30, 1998 PCT Filed May 26, 1997 PCT Pub. No. WO97/46512 PCT Pub. Date Dec. 11, 1997Stable, non-hygroscopic salts of L(-)carnitine and alkanoyl L(-)carnitines with mucic acid of formula (I) are disclosed wherein the molar ratio between the carnitine moiety and mucic acid is 2:1. A process for producing the salts and solid orally administrable compositions containing same are also disclosed.
Patent JP-H0695496-B2 (JP)
IPC: C23C16/44
Filed: 1983-12-14
Abstract: A method of fabricating a film of in-situ doped polycrystalline silicon having a surface that is free of microscopic hillocks includes the steps of providing a deposition chamber and a wafer therein on which the film is to be fabricated and introducing one gas containing silicon atoms and another gas containing dopant atoms into said chamber with respective flow rates; wherein the respective flow rates are gradually increased in an overdamped fashion over a start-up time interval of at least one minute from zero to respective steady state values while simultaneously the ratio of the respective flow rates is kept within 25% of the ratio of said steady state values.
Patent JP-S6356862-B2 (JP)
IPC: E04C2/20
Filed: 1980-04-16
Abstract: PCT No. PCT/NO80/00014 Sec. 371 Date Dec. 8, 1980 Sec. 102(e) Date Dec. 8, 1980 PCT Filed Apr. 16, 1980 PCT Pub. No. WO80/02303 PCT Pub. Date Oct. 30, 1980.A wall structure for vessels, tanks, washing towers, tubes, boat hulls and the like can be manufactured from elements consisting of a core of rigid plastic foam which on a first side is coated with a layer of non-expanded plastic which adheres to the core and preferably is of the same type as the latter, whereas the core is exposed on the opposite side. The elements have an elongated plank-like shape with opposite side surfaces having respective groove-and tongue-like design for matching mutual engagement. They can be rigidly engaged in side-by-side relationship by welding and/or gluing. On an exposed face of the assembled elements, a reinforced plastic mass which sets into a continuous layer is applied, if desired after grinding for evening out irregularities.
Patent JP-3950477-B2 (JP)
IPC: C07K14/805
Filed: 1996-06-05
Granted: 2007-08-01
Abstract: A method for separating unmodified hemoglobin from cross-linked hemoglobin in a hemoglobin solution. The method involves contacting the hemoglobin solution with a least one dissociating agent to form a dissociation solution wherein unmodified tetrameric hemoglobin is dissociated to form hemoglobin dimers. The hemoglobin dimers are then separated from the dissociation solution, while retaining the cross-linked hemoglobin in the dissociation solution.
Patent JP-2534207-B2 (JP)
IPC: A23K1/18
Filed: 1987-06-19
Granted: 1996-09-11
Abstract: PCT No. PCT/FR87/00233 Sec. 371 Date Apr. 18, 1988 Sec. 102(e) Date Apr. 18, 1988 PCT Filed Jun. 19, 1987 PCT Pub. No. WO87/07905 PCT Pub. Date Dec. 30, 1987.Method for producing a proteolytic complex formed after cultivation of a strain of Streptomyces fradiae while maintaining the pH of the culture medium between 7 and 7.5, and extracting said complex by filtration in the presence of a clarifying agent and ultrafiltration on a specific membrane and finally atomization; the invention also relates to the new proteolytic complex thus obtained and its applications in zootechny due to its stimulating effect on the activity of the pancreas.
Patent JP-2620821-B2 (JP)
IPC: C08L57/04
Filed: 1992-07-21
Granted: 1997-06-18
Abstract: PCT No. PCT/KR92/00033 Sec. 371 Date Feb. 4, 1994 Sec. 102(e) Date Feb. 4, 1994 PCT Filed Jul. 21, 1992 PCT Pub. No. WO93/04407 PCT Pub. Date Mar. 4, 1993.The present invention relates to a process for preparing a partially crosslinked binder resin useful for electrophotographic toner, which comprises: (1) preparing a partially crosslinked polymer by way of: a non-crosslinking emulsion polymerization of an aromatic vinyl monomer, an acrylic monomer and a cyanide compound in a linear structure, and a cross-linking polymerization of an aromatic vinyl monomer, an acrylic monomer, a cyanide compound and an unsaturated carboxylic acid or an unsaturated monomer containing an epoxy group; and (2) coagulating the polymer latex obtained in step(1) in the presence of a water soluble amine.
Patent JP-3232311-B2 (JP)
IPC: A41D31/02
Filed: 1991-02-28
Granted: 2001-11-26
Abstract: There is provided a laminated fabric comprising a sheet portion of a material compatible with human skin, the being adhered to a second sheet formed of a substantially impermeable material having perforations provided therethrough, each perforation having at least one relatively wide region and at least one relatively narrow region along its length to define an internal chamber open to a first ("inner") side of the sheet and sufficiently closed to the other ("outer") side of the sheet to permit air passing from the first to the other side of sheet to accumulate in the chamber under increased pressure prior to passing out to the other side of the sheet.
Patent JP-2911932-B2 (JP)
IPC: G02B6/42
Filed: 1989-04-28
Granted: 1999-06-28
Abstract: A method of splicing optical fibres in described in which at least one of the fibres has a high numerical aperture (NA) and the two fibres have different mode spot sizes. The method comprises fusing the ends of the fibres together with their cores in alignment and heating the fused junction between the fibres so as to cause dopant to migrate out of the core. The heating step is carried out for a time sufficient to achieve a predetermined level of matching between propagation modes in the two fibres.
Patent JP-H0819001-B2 (JP)
IPC: A23L1/308
Filed: 1990-04-20
Abstract: This invention encompasses a method and compositions which inhibit pancreatic cholesterol esterase and triglyceride lipase and hence, lower cholesterol and triglycerides in the blood stream.
Patent JP-3479780-B2 (JP)
IPC: A61K9/00
Filed: 1998-07-17
Granted: 2003-12-15
Abstract: Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.
Patent JP-2683296-B2 (JP)
IPC: A61K31/715
Filed: 1992-05-25
Granted: 1997-11-26
Abstract: The invention concerns oligodeoxyribonucleotides, in which, at both the 5' and the 3' terminal positions, at least two 2'-deoxy-$g(b)-D-erythro-pentofuranosyl groups have been replaced by 2'-deoxy-$g(b)-D-threo-pentofuranosyl groups, and oligodeoxyribonucleotides in which at least 20 % of the 2'-deoxy-$g(b)-D-erythro-pentofuranosyl groups in successive nucleotide units have been replaced by 2'-deoxy-$g(b)-D-threo-pentofuranosyl groups, and which consist of 6 to 100 nucleotide units. Such oligodeoxyribonucleotides are suitable for use as anti-sense inhibitors of the expression of viral genes and oncogenes and can be used in the preparation of drugs with an anti-viral action.
Patent JP-2876257-B2 (JP)
IPC: C03C27/06
Filed: 1993-03-18
Granted: 1999-03-31
Abstract: An insulating glass unit is shown comprising a pair of generally parallel, spaced-apart glass panes and a spacer peripherally joining the glass panes to each other. The spacer is a tubular structure, and may include a particulate desiccant filling at least a section of the interior and conforming to the interior configuration thereof to contribute compressive strength to the spacer. The spacer desirably is made from stainless steel sheeting having a thickness not greater than about 0.005 inches. In a preferred embodiment, the spacer includes side walls sealed to the glass panes and an outer wall extending between the side walls and having a sealant free portion between the side walls that extends substantially completely about the periphery of the glass unit.
Patent JP-3165157-B2 (JP)
IPC: A61L2/20
Filed: 1995-11-28
Granted: 2001-05-14
Abstract: PCT No. PCT/DK95/00470 Sec. 371 Date Jul. 1, 1997 Sec. 102(e) Date Jul. 1, 1997 PCT Filed Nov. 28, 1995 PCT Pub. No. WO96/16555 PCT Pub. Date Jun. 6, 1996A method and apparatus for disinfection or sterilizing an article which is a food or foodstuff, or a surface of an article for contacting a food or foodstuff. According to the invention, the article is grounded and is treated with an electrically charged mist of a liquid having a redox potential and a predetermined pH. The mist is subsequently evaporated from the article.
Patent JP-3220987-B2 (JP)
IPC: C07D231/14
Filed: 1997-10-22
Granted: 2001-10-22
Abstract: 1-Phenylpyrazole compounds of the formula (1): <CHEM> which is exemplified by 5-amino-1-(3-cyano-4-isobutoxyphenyl)pyrazole-4-carboxylic acid, an optical isomer thereof and a pharmaceutically acceptable salt thereof. These compounds have a xanthine oxidase inhibitory activity and are useful as therapeutic agents for diseases such as hyperuricacidemia and gout.
Patent JP-3647453-B2 (JP)
IPC: B32B15/18
Filed: 1995-01-12
Granted: 2005-05-11
Abstract: PCT No. PCT/SE95/00020 Sec. 371 Date Dec. 4, 1996 Sec. 102(e) Date Dec. 4, 1996 PCT Filed Jan. 12, 1995 PCT Pub. No. WO95/19861 PCT Pub. Date Jul. 27, 1995The invention relates to a method for the manufacturing of a composite metal product. More particularly, the invention relates to a method for the manufacturing of a composite product consisting of at least two stainless steel materials having different chemical compositions, particularly a composite stainless product on which decorative patterns can or has been produced by etching. It is significant feature of the invention that at least two stainless steel materials having different chemical compositions are bonded together through hot isostatic compaction at a pressure exceeding 600 bar and a temperature exceeding 1000 DEG  C., at least one of said materials consisting of powder, for the achievement of a consolidated body.
Patent JP-4348442-B2 (JP)
IPC: H04L12/56
Filed: 1995-02-01
Granted: 2009-10-21
Abstract: PCT No. PCT/DE95/00121 Sec. 371 Date Sep. 18, 1996 Sec. 102(e) Date Sep. 18, 1996 PCT Filed Feb. 1, 1995 PCT Pub. No. WO95/21508 PCT Pub. Date Aug. 10, 1995A process for transmitting data in packets in a radio system with mobile and base stations labels the packets with indentification or code numbers which are used to route the packets over data traffic channels characterized in the allocated control channels as those containing the data packets by means of the identification number.
Patent JP-3821842-B2 (JP)
IPC: A61N1/30
Filed: 1995-04-07
Granted: 2006-09-13
Abstract: An electrotransport apparatus using dispersed ion exchange material (19,93) is disclosed. The ion exchange material (19,93) may be dispersed in either the donor electrode assembly (10), the counter electrode assembly (10) or both electrode assemblies. The dispersed ion exchange material (93) comprises mobile ionic species (C2) and substantially immobile ionic species (P). The dispersed ion exchange material (93) is consumed during electrotransport of drug or agent (A) in an electrotransport process in which substantially no species which compete with the drug or agent for electrotransport are generated. Electrotransport devices exhibiting reduced polarization are also disclosed.
Patent JP-3929501-B2 (JP)
IPC: H04N19/467
Filed: 1998-01-12
Granted: 2007-06-13
Abstract: The method involves encoding the signal in accordance with a given encoding process, including feeding back the encoded signal to control the encoding. The encoded signal is modified to represent the supplemental data, and the feeding back of the encoded signal is carried out after the signal modification. The encoding is preferably a unit bit encoding, with sigma delta modulation. The modification of the encoded signal may comprise the replacement of selected samples of the encoded signal by samples of the supplemental data.
Patent JP-4037448-B2 (JP)
IPC: H01M8/04
Filed: 1996-05-24
Granted: 2008-01-23
Abstract: A fuel gas and an oxygen containing gas are supplied downwardly through different passages into a first manifold plate 42, a first surface pressure generating plate 44, a separator body 48, a second surface pressure generating plate 46, a second manifold plate 50, a first gasket 30, a solid polymer electrolyte membrane 22, and a second gasket 32, into which cooling water is supplied upwardly. The cooling water rises upwardly in the separator body 48 to reduce a temperature distribution in a fuel cell 20. <IMAGE>
Patent ES-2299360-B2 (ES)
Title: Maquina para atar embutidos.
Inventor: ANDUJAR VILA ELISEO
IPC: A22C11/12
Filed: 2006-07-07
Granted: 2008-12-16
Abstract: Máquina para atar embutidos, que presenta tres diferentes motores para controlar las principales acciones de la máquina como son la apertura y cierre de unos estranguladores del embutido, la acción de enrollar el hilo alrededor del embutido y el movimiento de las cintas de arrastre del embutido, una vez ha sido atado, el mecanismo de posicionamiento de los estranguladores permite evitar accidentes y facilita la limpieza de la máquina, las cintas de arrastre del embutido, por su configuración, pueden adoptar diferentes posiciones.
Patent ES-2328002-B2 (ES)
Title: Uso combinado de metil-jasmonato y ciclodextrinas para la produccion de resveratrol.
Inventor: PEDRENO GARCIA MARIA ANGELES
IPC: C12N5/04
Filed: 2008-02-29
Granted: 2010-03-29
Abstract: Uso combinado de metil-jasmonato
y ciclodextrinas para la producción de  resveratrol. 
     El uso combinado de
metil-jasmonato y ciclodextrinas para la promover la
 producción de resveratrol por parte de células capaces de
sintetizar este  compuesto y la acumulación extracelular del
mismo.
Patent ES-2558590-B2 (ES)
Title: Dispositivo de fijación, cierre y acoplamiento para catéter de perfusión intravenosa
Inventor: BLAYA HARO FERNANDO
IPC: A61M25/02
Filed: 2014-08-05
Granted: 2016-11-17
Abstract: Dispositivo de fijación, cierre y acoplamiento para catéter de perfusión intravenosa.#La presente invención se refiere a un sistema mecánico de fijación, cierre y acoplamiento para catéter de perfusión intravenosa. El sistema dispone de una pieza circular de pequeño espesor (2) con al menos dos orificios para su fijación (5) subcutánea, centralmente de uno o más conductos para acoplar lúmenes (3), y de una parte cilíndrica hueca que sobresale a uno de los lados (6), exteriormente roscada e interiormente lisa con un tetón de posición (4). Para uso domiciliario se dispone de un tapón de estanqueidad (7) con uno o más tubos de pequeño diámetro (9) que se acoplan en los orificios para lúmenes (3), una ranura de posición (10), un tirador (11), y un tapón roscado ciego (8) para el cierre hermético con la parte roscada (6). Para uso hospitalario se dispone de un tapón intermedio (12) con una o más entradas para lúmenes, y de un tapón roscado hueco (13) que permite su acoplamiento hermético con la parte roscada (6).
Patent ES-2610432-B2 (ES)
Title: Catalizadores de aluminio muy activos en ROP de glicidil metacrilato
Inventor: MUNOZ FERNANDEZ MARÍA TERESA
IPC: C08G65/22
Filed: 2015-10-27
Granted: 2017-09-11
Abstract: Catalizadores de aluminio muy activos en ROP de glicidil metacrilato. La presente invención consiste en un procedimiento mejorado para la polimerización por apertura de anillo del grupo oxirano del glicidil metacrilato. En concreto, se trata de la síntesis de compuestos de aluminio del tipo (3) y de las aplicaciones que estos compuestos tienen como catalizadores en la polimerización ROP del glicidil metacrilato en ausencia de iniciadores o cocatalizadores a temperatura ambiente y en periodos cortos de tiempo.
Patent ES-2586469-B2 (ES)
Title: Sistema de deslastre de cargas para redes con motores de elevada potencia
Inventor: PLATERO GAONA CARLOS ANTONIO
IPC: H02J3/14
Filed: 2015-04-13
Granted: 2018-02-16
Abstract: Sistema de deslastre de cargas para instalaciones consumidoras con motores de elevada potencia.#Sistema de deslastre de cargas para instalaciones aisladas consumidoras con motores basada en la comparación de la velocidad y/o la variación de la velocidad en el tiempo de los motores con unos umbrales previamente ajustados que desconectan los diferentes motores si su velocidad y/o la variación de la misma no supera dichos umbrales.
Patent ES-2648369-B2 (ES)
Title: Nuevas formas sólidas de desvenlafaxina
Inventor: DOMINGUEZ CHAVEZ JORGE GUILLERMO
IPC: C07C215/64
Filed: 2017-06-28
Granted: 2018-06-08
Abstract: La presente invención se refiere a nuevas formas sólidas amorfas y cristalinas de desvenlafaxina, también llamado O-desmetilvenlafaxina o desmetilvenlafaxina, y a sus sales, solvatos, hidratos y polimorfos de las mismas, así como a su uso en la preparación de una composición farmacéutica útil para el tratamiento de la depresión y/o inhibidor selectivo de la reabsorción de serotonina y la norepinefrina así como a los trastornos vasomotores asociados a la menopausia.
Patent AU-2001240662-B2 (AU)
Title: Method for the esr-spectroscopic detection of changes in the transport properties of albumin in an albumin-containing sample, esr-spectrometer for carrying out said method, and use of the method for diagnostic purposes and for controlling albumin-containing preparations
Inventor: MILUTIN ALEXANDER
IPC: G01R33/32
Filed: 2001-02-28
Granted: 2006-04-27
Abstract: The invention relates to method for the ESR-spectroscopic detection of changes in the transport properties of albumin in an albumin-containing sample. Said method can be used in the medical, biological, biotechnological and veterinary praxis for diagnostic purposes and/or for monitoring physiological or pathological changes in the human or animal body or for the quality control of albumin-containing preparations, especially blood products. The invention further relates to an ESR spectrometer for carrying out the inventive method, which-being an automated ESR analyzer-allows for a simple and reliable handling required in modern clinical laboratories. The inventive ESR spectrometer integrates automatic device controls, signal registration and signal evaluation in combination with a computer program for the diagnostic analysis of the measured data.
Patent AU-2002235483-B2 (AU)
Title: Water spout with removable laminar flow cartridge
Inventor: FREIER DONALD P
IPC: B05B1/02
Filed: 2002-01-29
Granted: 2006-10-26
Abstract: A water spout is capable of providing laminar flowing fluid from a wall-mounted or faucet fixture body. The fixture body defines a cavity and a port for connection of a plumbing supply line. A cartridge assembly is disposed in the body cavity. The cartridge has a housing with an inlet opening and an outlet opening in fluid communication with the port. The cartridge housing contains a plurality of elements between the inlet and outlet openings for smoothing the flow of fluid passing through the cartridge assembly. A nozzle, positioned adjacent the outlet opening of the cartridge, has a sharp-edged orifice through which fluid leaving the fixture can be projected in a single laminar stream. The nozzle can be removed from the fixture body after the fixture body has been mounted for use such that all of the flow smoothing elements can be removed at once by removing the cartridge assembly from the cavity.
Patent AU-2002329929-B2 (AU)
Title: Improved methods for producing oocysts
Inventor: TYCZKOWSKI JULIUS K
IPC: A61K39/012
Filed: 2002-08-29
Granted: 2005-11-03
Abstract: The present invention provides improved methods and compositions for producing oocysts. The oocysts produced according to the invention find use in the manufacture of vaccines. In preferred embodiments, the present invention provides methods and compositions for the production of Eimeria oocysts. Vaccines containing Eimeria oocysts, sporocysts and/or sporozoites produced according to the present invention may be used to immunize birds against coccidiosis either in ovo or post hatch.